<DOC>
	<DOCNO>NCT00005081</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine carmustine O6-benzylguanine treating patient recurrent progressive glioma .</brief_summary>
	<brief_title>Carmustine Plus O6-benzylguanine Treating Patients With Recurrent Progressive Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine activity carmustine O6-benzylguanine patient recurrent progressive glioblastoma multiforme , anaplastic astrocytoma , gliosarcoma resistant nitrosourea . II . Determine toxic effect regimen patient . OUTLINE : Patients receive O6-benzylguanine IV 1 hour , follow 1 hour later carmustine IV 1 hour day 1 . Treatment repeat every 6 week absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 18-32 patient accrue study within 12-18 month .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>O ( 6 ) -benzylguanine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent progressive glioblastoma multiforme , anaplastic astrocytoma , gliosarcoma Resistant nitrosourea ( defined progressive recurrent disease within 8 week receive nitrosourea ) Measurable residual disease MRI CT scan PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hemoglobin great 10 g/dL Hepatic : Bilirubin normal SGOT great 2.5 time upper limit normal Renal : Creatinine great 1.5 mg/dL BUN great 25 mg/dL Pulmonary : DLCO great 80 % predict Other : Not pregnant nursing Fertile patient must use effective contraception 2 month study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 4 week since prior chemotherapy At least 6 week since prior nitrosourea , procarbazine , mitomycin recover No prior nitrosourea great 1,200 mg/m2 Endocrine therapy : Concurrent stable dose corticosteroid allow least two week prior study Radiotherapy : At least 4 week since prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>